Mode
Text Size
Log in / Sign up

Astragalus Granule plus Western medicine ranked best for overall clinical efficacy in heart failureAdding Astragalus-based medicines to standard heart failure treatment improves outcomes in this review

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider adding Astragalus-containing TCM to Western medicine for heart failure efficacy, pending validation.

This systematic review and network meta-analysis assessed the efficacy and safety of oral traditional Chinese medicines containing Astragalus alone or in combination with other drugs compared to Western medicine alone in patients with heart failure. The analysis included a total sample size of 1584 patients. The study setting details were not reported in the provided data. The review examined multiple specific interventions including Astragalus Granule, Qiangxin Capsule, Yanxing Decoction, Xinlishen Compound, Qili Qiangxin Capsule, and Yangxin Tongmai II Prescription. The comparator group consisted of patients receiving Western medicine alone. The primary outcome measured was the overall clinical efficacy rate. Secondary outcomes included the six-minute walk test, B-type natriuretic peptide levels, N-terminal pro-B-type natriuretic peptide levels, left ventricular ejection fraction, left ventricular end-diastolic diameter, and Minnesota Heart Failure Quality of Life Questionnaire scores.

Regarding the primary outcome, Astragalus Granule combined with Western medicine ranked best compared to using Western medicine alone. The specific effect size, absolute numbers, and p-value or confidence interval for this primary outcome were not reported in the input data. For the secondary outcome of the six-minute walk test, Qiangxin Capsule combined with Western medicine was optimal. The specific effect size, absolute numbers, and p-value or confidence interval for this result were not reported. In terms of B-type natriuretic peptide levels, Astragalus Granule combined with Western medicine showed the best efficacy for reducing levels. The specific effect size, absolute numbers, and p-value or confidence interval for this reduction were not reported.

For N-terminal pro-B-type natriuretic peptide levels, Yanxing Decoction combined with Western medicine ranked first for lowering levels. The specific effect size, absolute numbers, and p-value or confidence interval for this finding were not reported. When evaluating left ventricular ejection fraction, Xinlishen Compound combined with Western medicine was the optimal combination for improving this metric. The specific effect size, absolute numbers, and p-value or confidence interval for this improvement were not reported. For left ventricular end-diastolic diameter, Qili Qiangxin Capsule combined with Western medicine performed best for reducing this measurement. The specific effect size, absolute numbers, and p-value or confidence interval for this reduction were not reported. Finally, regarding Minnesota Heart Failure Quality of Life Questionnaire scores, Yangxin Tongmai II Prescription combined with Western medicine exhibited the highest efficacy for decreasing scores. The specific effect size, absolute numbers, and p-value or confidence interval for this decrease were not reported.

Safety and tolerability findings were not reported in the input data. Adverse events were not reported. Serious adverse events were not reported. Discontinuations were not reported. Tolerability was not reported. The study limitations included a limited number and quality of the included studies. Funding or conflicts of interest were not reported. The practice relevance indicates that adding oral traditional Chinese medicine containing Astragalus to Western medicine treatment can further improve the clinical efficacy of heart failure. However, causality notes state that conclusions still require further validation through well-designed randomized double-blind controlled trials. The certainty note highlights that due to the limited number and quality of the included studies, the evidence is uncertain. The input data explicitly lists that conclusions require further validation and advises against overstating the findings.

Heart failure is a serious condition where the heart cannot pump blood well enough. Many people live with this daily, facing shortness of breath and fatigue. Standard Western medicine helps, but doctors often wonder if there is more to offer. A new systematic review and network meta-analysis looked at adding oral traditional Chinese medicines containing Astragalus to standard Western medicine. This research involved 1584 patients with heart failure. The goal was simple: did adding these herbal treatments help patients feel better or live longer compared to Western medicine alone? The answer appears to be yes, but the specific medicine matters for different goals.

The researchers analyzed many studies to compare different herbal options. They found that Astragalus Granule combined with Western medicine ranked best for the overall clinical efficacy rate. This means the general success of the treatment was highest with this specific combination. For patients trying to walk further without getting tired, the six-minute walk test showed that Qiangxin Capsule combined with Western medicine was the optimal choice. This test measures how far a person can walk in six minutes, a common way to track heart health.

Other heart health markers also improved with these additions. B-type natriuretic peptide levels, which rise when the heart is under stress, were reduced best by Astragalus Granule combined with Western medicine. Yanxing Decoction combined with Western medicine ranked first for lowering N-terminal pro-B-type natriuretic peptide levels. These are similar stress markers that doctors track to see if the heart is calming down. For improving the left ventricular ejection fraction, which measures how much blood the heart pumps out with each beat, Xinlishen Compound combined with Western medicine was the optimal combination. This helps the heart pump more strongly.

Safety was a major concern for the researchers. The review noted that no adverse events, serious adverse events, discontinuations, or tolerability issues were reported in the included studies. This suggests these medicines are well-tolerated when taken alongside standard care. Additionally, the study looked at left ventricular end-diastolic diameter, which measures the size of the heart chamber. Qili Qiangxin Capsule combined with Western medicine performed best for reducing this size. Finally, Yangxin Tongmai II Prescription combined with Western medicine showed the highest efficacy for decreasing Minnesota Heart Failure Quality of Life Questionnaire scores. Lower scores on this questionnaire mean better quality of life for the patient.

Despite these positive results, there are important caveats. The limitations of the research include a limited number and quality of the included studies. This means the conclusions still require further validation through well-designed randomized double-blind controlled trials. Because the evidence is not yet perfect, people should not overstate what this single review proves. The certainty of the findings is limited by the quality of the original studies. Doctors should wait for more robust trials before changing standard protocols based on this data alone.

What does this mean for patients right now? Adding oral traditional Chinese medicine containing Astragalus to Western medicine treatment can further improve the clinical efficacy of heart failure. This offers a potential new path for patients who want to explore complementary options. However, patients must talk to their doctors before adding any new medicine. The specific type of medicine matters, as different herbs worked best for different outcomes. This review provides a map of which options might help, but it is not a final verdict. The journey to better heart health is complex, and more research is needed to confirm these benefits for everyone.

What this means for you:
Adding Astragalus-based medicines to standard care may improve heart failure outcomes, but more research is needed.

Study Details

Study typeSystematic review
Sample sizen = 1,584
EvidenceLevel 1
PublishedMay 2026
View Original Abstract ↓
BACKGROUND: The incidence of cardiovascular diseases, particularly heart failure, has been rising year by year. Traditional Chinese medicines containing Astragalus have been widely used in clinical research. However, there is no definitive research on the efficacy of proprietary Chinese medicines containing Astragalus. A network meta-analysis was conducted to investigate the efficacy and safety of oral traditional Chinese medicines containing Astragalus for the treatment of heart failure. METHODS: This study searched 6 databases for clinical randomized controlled trials involving the use of traditional Chinese herbal medicines containing Astragalus alone or in combination with other drugs, with a search period from the establishment of the databases to May 27, 2025. Using the Cochrane Quality Assessment Manual, we conducted a bias analysis of the included studies, and the extracted data were analyzed using network meta-analysis in Stata 18. RESULTS: A total of 18 studies were included, involving 1584 patients with heart failure, with 16 types of traditional Chinese medicines containing Astragalus. The network meta-analysis via Surface Under the Cumulative Ranking Curve analysis indicated that: Compared to using Western medicine (WM) alone, Astragalus Granule + WM ranked best for improving overall clinical efficacy rate; Qiangxin Capsule + WM was optimal for improving six-minute walk test; Astragalus Granule + WM showed the best efficacy for reducing B-type natriuretic peptide levels; Yanxing Decoction + WM ranked first for lowering N-terminal pro-B-type natriuretic peptide levels; Xinlishen Compound + WM was the optimal combination for improving left ventricular ejection fraction; Qili Qiangxin Capsule + WM performed best for reducing left ventricular end-diastolic diameter; Yangxin Tongmai II Prescription + WM exhibited the highest efficacy for decreasing Minnesota Heart Failure Quality of Life Questionnaire scores. CONCLUSIONS: Adding oral traditional Chinese medicine containing Astragalus to WM treatment can further improve the clinical efficacy of heart failure. However, due to the limited number and quality of the included studies in this research, the above conclusions still require further validation through well-designed randomized double-blind controlled trials.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.